this post was submitted on 17 Jul 2023
146 points (99.3% liked)

Technology

73939 readers
3388 users here now

This is a most excellent place for technology news and articles.

Our Rules

  1. Follow the lemmy.world rules.
  2. Only tech related news or articles.
  3. Be excellent to each other!
  4. Mod approved content bots can post up to 10 articles per day.
  5. Threads asking for personal tech support may be deleted.
  6. Politics threads may be removed.
  7. No memes allowed as posts, OK to post as comments.
  8. Only approved bots from the list below, this includes using AI responses and summaries. To ask if your bot can be added please contact a mod.
  9. Check for duplicates before posting, duplicates may be removed
  10. Accounts 7 days and younger will have their posts automatically removed.

Approved Bots

founded 2 years ago
MODERATORS
L3s@lemmy.world
enu@lemmy.world
technopagan@lemmy.world
L4s@lemmy.world
L3s@hackingne.ws
L4s@hackingne.ws
146
Eli Lilly drug shown to slow Alzheimer’s progression (arstechnica.com)
submitted 2 years ago by PopBobert@lemmy.world to c/technology@lemmy.world
10 comments fedilink hide all child comments
 

Dementia experts hail "watershed moment" after trial results for donanemab antibody treatment.

you are viewing a single comment's thread
view the rest of the comments
[–] partial_accumen@lemmy.world 11 points 2 years ago (1 children)

It cleared amyloid plaques completely from the brain in some participants, who were then taken off the drug.

What was the result to the patient outcomes? Did the patients return to pre-demenia state or did their demenia progress simply halt when all the amyloid is cleared (from those patients that got completely cleared of amyloid)?

[–] Regna@lemmy.world 1 points 2 years ago

Sorry, I pressed reply in Voyager, but it ended up as a comment to my post instead of a reply to your comment.